Variants and Vaccine Hesitancy Means U.S. Unlikely to Reach Herd Immunity, Experts Conclude
Despite a strong vaccine rollout, getting the U.S. to the other side of the pandemic any time soon seems like a far reach, experts conclude.

Owen Humphreys via Reuters
A combination of new coronavirus variants and increasing vaccine hesitancy means that despite a strong vaccine rollout, the U.S. won’t likely reach herd immunity any time soon, The New York Times reports. More than half of all American adults have received at least one dose of an anti-COVID-19 vaccine, but the number of people signing up for their second dose or to be inoculated at all is waning, according to latest data. The Biden administration’s top adviser, Dr. Anthony Fauci, has admitted that the promise of herd immunity now seems a far reach but the infections will eventually go down. “People were getting confused and thinking you’re never going to get the infections down until you reach this mystical level of herd immunity, whatever that number is,” he said, according to the Times.“That’s why we stopped using herd immunity in the classic sense. I’m saying: Forget that for a second. You vaccinate enough people, the infections are going to go down.”
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.